Silence Therapeutics to proceed with AIM delisting next week

(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced on 15 October.
The company confirmed that the last day of trading of its ordinary shares on AIM would be 29 November, with the proposed delisting to become effective at 0700 GMT on 30 November.

Silence said it would retain the listing of its American depositary shares (ADS), each representing three ordinary shares, on the Nasdaq Global Market under the symbol SLN.

"Following the AIM delisting, the company's ADSs will remain listed, and will only be tradeable, on Nasdaq," the board said in its statement.

"Following delisting, Investec Bank will cease to act as nominated adviser and broker to the company."

At 0933 GMT, shares in Silence Therapeutics were down 1.45% at 542p.